F10 and atrial fibrillation: The ENGAGE AF‐TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48) trial showed that overweight and obese patients with AF had lower risk of stroke and systemic embolism compared with normal weight patients [40].